Comparing Robotic and Open Surgery for Pancreatoduodenectomy in Pancreatic Cancer Across Multiple Spanish Hospitals
Led by Hospital del Mar · Updated on 2026-07-08
120
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Pancreatoduodenectomy PD, also known as the Whipple procedure, is a complex surgery often required for pancreatic and other periampullary cancers. This national, multicenter study in Spain compares robotic-assisted PD to traditional open PD surgery. The aim is to evaluate which surgical approach results in fewer complications within 90 days after surgery. The study uses a prospective, randomized design and involves multiple hospitals with experienced surgeons.
Participants will be randomly assigned to either robotic or open PD surgery. The robotic approach uses the da Vinci system for the pancreatic and biliary connections, while the open approach follows standard laparotomy procedures. The study lasts two years, and patients will be followed for three years to assess long-term outcomes. Both techniques will be monitored for complications, blood loss, operative time, conversion rates, and oncological outcomes among cancer patients.
During the study, participants will undergo surgery according to their assigned group. Data on complications, quality of life, hospital stay duration, surgical costs, and recovery will be collected using standardized scales and questionnaires up to 90 days and beyond. Follow-up includes monitoring for readmissions, need for reoperations, and long-term tumor outcomes. Safety and economic data will also be recorded, with confidentiality maintained through coded patient data. The total participation may last several years to capture extended outcomes.
CONDITIONS
Brief Title
Robotic vs Open Pancreatoduodenectomy
Research Team
B
Benedetto Ielpo, PhD, MD, FACS, FEBS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients requiring planned pancreatoduodenectomy (robotic or open)
Signed informed consent to participate in the study
You will not qualify if you...
Patients who refuse the procedure
Uncertainty about vascular involvement that could affect resectability
Poor general health status (American Society of Anesthesiologists [ASA] classification IV)
Pancreatitis
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Surgery day
Participants undergo either robotic-assisted or open pancreatoduodenectomy surgery as assigned.
1 surgery visit
Follow-up
Duration - Up to 3 years
Participants are monitored for complications, recovery, quality of life, and cancer outcomes for up to 3 years after surgery.
Regular follow-up visits during the first 90 days and extended monitoring
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study Comparing Two Types of Gastrojejunostomy After Pancreaticoduodenectomy to Reduce Delayed Gastric Emptying
Phase II Study of Dostarlimab and Oral Vitamin D3 Combined with mFOLFIRINOX Chemotherapy for Untreated Metastatic Pancreatic Adenocarcinoma in Adults Aged 18 to 75
Quality of Life and Patient Satisfaction After Pancreatic Surgery for Pancreas Conditions
Comparing Robotic and Open Surgery for Pancreatoduodenectomy in Pancreatic Cancer Across Multiple Spanish Hospitals
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial.
The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials.
Ksenija Slankamenac, Nina Nederlof, Patrick Pessaux...
Robotic versus open pancreatoduodenectomy (SPAIN Trial): protocol for a multicenter randomized controlled trial assessing safety, efficacy and cost-effectiveness.
Alberto Carrancho, Danilo Vinci, Fernando Burdio...